Stephen J. Nicholls, MD, PhD

home / authors / stephen-j-nicholls-md-phd

Professor Stephen Nicholls is a world-renowned cardiologist, and leads the Victorian Heart Hospital (VHH) at Monash University.

Articles

Stephen Nicholls, MBBS, PhD | Credit: Monash University

Phase 2 Data Support Muvalaplin for Lowering Lp(a), with Stephen Nicholls, MBBS, PhD

Stephen J. Nicholls, MD, PhD;Patrick Campbell
November 21st 2024

Stephen Nicholls, MBBS, PhD, provides additional insight into KRAKEN trial data and the potential of muvalaplin.

Read More

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD

Stephen J. Nicholls, MD, PhD;Patrick Campbell;Connor Iapoce
November 20th 2024

Stephen J. Nicholls, MD, PhD discusses the robust efficacy and tolerability of zerlasiran for Lp(a) lowering, paving the way for Phase 3 development.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 16th 2024 | Updated: December 22nd 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: November 15th 2024 | Updated: December 22nd 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 22nd 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 22nd 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.